Science Advisory and Grant Review Board
Kevin B. Clark, PhD
Faculty, University of California Los Angeles; Principal Investigator/Consultant, Veterans Affairs Greater Los Angeles Healthcare System
Kevin B. Clark, Ph.D. is Affiliate Faculty at the California NanoSystems Institute at the University of California Los Angeles and Principal Investigator/Consultant with the Research and Development Service at the Veterans Affairs Greater Los Angeles Healthcare System. His academic lineage includes six Nobel laureates and additional distinguished scientists. Among other professional activities, Dr. Clark serves or has served as Member of many professional societies: Editor for professional journals and technical books: Member of proprietary and independent nonprofit science advisory boards for new and rediscovery medical science and clinical practice: Senior Scientist and Vice President of Finance and Partnership Development at the Complex Biological Systems Alliance (a nonprofit consortium of scientists and technologists from Ivy League, Oxbridge, and other highly ranked institutions): Consultant/Collaborator with the Extreme Science and Engineering Discovery Environment at the University of Illinois’ National Center for Supercomputing Applications and the Biological Collaborative Research Environment at the University of Illinois’ NIH Center of Macromolecular Modeling and Bioinformatics: and Technical Advisor for STEM scholastic and community out-reach programs sponsored by the Society for Neuroscience, the Howard Hughes Medical Institute, FIRST, and The Franklin Foundation, where he sits on the Board of Directors.
Dr. Clark’s award-winning research and patented inventions improving learning, memory, and recovery from traumatic brain injury through peripheral neuromodulation gained recognition from MacArthur fellow Dr. James McGaugh and other members of the National Academy of Sciences, USA. This work was instrumental in the US Food and Drug Administration’s decision to approve Vagus Nerve Stimulation (VNS) for complex-partial seizures – the only medical device currently marketed for treatment of convulsive epilepsy – and has encouraged potential derivative medical indications for VNS, including treatments for Alzheimer's disease, traumatic brain injury, post-traumatic stress disorder, and tinnitus, among other pathologies. Complementing this area of endeavor, Dr. Clark’s more recent work concentrates on rational design and application of smart pharmaceuticals, such as drugs and nano-/microscale devices important for next-generation smart theragnostic and regenerative medical technologies.